Centiva Capital’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
3,786
-1,888
-33% -$160K ﹤0.01% 1270
2026
Q1
$564K Buy
+5,674
New +$740K ﹤0.01% 785
2025
Q3
Sell
-5,627
Closed -$754K 1842
2025
Q2
$754K Buy
+5,627
New +$618K 0.01% 754
2025
Q1
Sell
-31,087
Closed -$1.94M 2128
2024
Q4
$1.94M Buy
31,087
+18,943
+156% +$1.76M 0.04% 347
2024
Q3
$1.91M Sell
12,144
-608
-5% -$93.7K 0.04% 480
2024
Q2
$1.92M Sell
12,752
-514
-4% -$61.7K 0.03% 442
2024
Q1
$981K Buy
+13,266
New +$1.09M 0.02% 669

Other funds holding TMDX

Centiva Capital's TMDX Position: Q2 2026 in Review

Centiva Capital reduced its Transmedics (TMDX) stake by 33% in Q2 2026, selling an estimated $160K and leaving 3,786 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Centiva Capital first reported a position in TMDX in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.94M in Q4 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Centiva Capital held 3,786 shares of Transmedics worth $251K as of Q2 2026.
  • Centiva Capital sold 1,888 Transmedics shares in Q2 2026, an estimated $160K.
  • Transmedics made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1270 holding.
  • Centiva Capital first reported a position in Transmedics in Q1 2024 and has held it in 7 quarters since.
  • Centiva Capital's Transmedics position peaked at $1.94M in Q4 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.